Study of adults with fatty liver and NASH over time
Part of Digestive system clinical trials.
This is a long-term study that follows adults who are being managed for fatty liver (NAFL) or NASH to learn how these conditions change over time. It may help researchers better understand what to expect and how care decisions could be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have been diagnosed with NAFL or NASH and are currently being managed or treated for it
- You can talk with the study team and sign consent in writing
- You do not drink more than 14 alcoholic drinks per week (if you’re male) or more than 7 per week (if you’re female)
- Your fatty liver is not mainly caused by another problem (like certain infections, specific liver conditions such as Wilson’s disease, starvation, or feeding through a vein)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with fatty liver to learn more about how it progresses and what patterns are common. It may help improve future ways of identifying and monitoring fatty liver.
This study follows people with nonalcoholic fatty liver disease to better understand the condition. It uses an MRI scan and collects body samples to help researchers study changes over time.
This study follows older adults with fatty liver disease to understand how their metabolism changes over time and how it affects their overall health. It helps researchers learn more about the condition and its impact on the body outside the liver.
This study tracks the progression of fatty liver disease and NASH in Chinese patients. It aims to better understand how the condition develops over time, which may help improve future treatments and care.
This study looks at adults with different long-term liver conditions that are associated with fatty liver. It helps researchers better understand these diseases and factors linked to them.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
Hear when a new Non-Alcoholic Fatty Liver Disease (NAFLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.